FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileLevitee Labs Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LVTTF
Levitee Labs Inc. Stock AnalysisComprehensive stock analysis for Levitee Labs Inc. (LVTTF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLVTTF
LVTTF
Levitee Labs Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LVTTF
  1. Home
  2. Stocks
  3. Levitee Labs Inc.

Levitee Labs Inc.

🇺🇸LVTTF•OTC

Levitee Labs Inc.

🇺🇸LVTTF•OTC
Market cap
$369.15K

Your view on LVTTF

Mkt Cap
$369.15K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Levitee Labs Inc.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
David Bentil
Headquarters
800 West Pender Street, Vancouver, BC, CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
David Bentil
Headquarters
800 West Pender Street, Vancouver, BC, CA
Description

Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products.

It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions.

The company operates five clinics under the Levitee Clinics name; and three pharmacies in Alberta under the Levitee Pharmacies name. In addition, it offers electronic-prescriptions in the addiction treatment space under the BlockMD name; and wholesales supplements and superfood under the Earth Circle Organics name.

The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.

FRC Research

Past Reports

Historical coverage archive.

1 report
Nov 8, 2021

Building a Chain of Mental Health/Addiction Clinics & Pharmacies for the Burgeoning Psychedelic Sector – Initiating Coverage

PDF
Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Levitee Labs Inc.. Starting points for Levitee Labs Inc.: EPS -$0.27, beta 0.28 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Levitee Labs Inc.. Levitee Labs Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Levitee Labs Inc.. Trailing twelve-month EPS for Levitee Labs Inc. stands at -$0.27. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · CAD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent YearFY Sep 2023Next YearFY Sep 2024
Avg. estimateCAD 0.04CAD 0.07
Low estimateCAD 0.04CAD 0.07
High estimateCAD 0.04CAD 0.07
No. of analysts11
Year-ago EPS——
Growth——

Revenue Estimate

RevenueCurrent YearFY Sep 2023Next YearFY Sep 2024
Avg. estimateCAD 23.64MCAD 33.21M
Low estimateCAD 23.64MCAD 33.21M
High estimateCAD 23.64MCAD 33.21M
No. of analysts11
Year-ago revenue——
Growth——

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Levitee Labs Inc.. Levitee Labs Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold LVTTF20 companies
Compare LVTTF with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
CNNXFCannAmerica Brands Corp.HealthcareMedical - Pharmaceuticals$704
CSTFCuraScientific CorpHealthcareDrug Manufacturers - Specialty & Generic$377,345
GBHPFGlobal Hemp Group Inc.HealthcareDrug Manufacturers - Specialty & Generic$123,886
INSOIndustry Source Consulting, Inc.IndustrialsSpecialty Business Services$16,764
LTHOLegacy Technology Holdings, Inc.HealthcareDrug Manufacturers - Specialty & Generic$1,720
MGWFFMaple Leaf Green World Inc.IndustrialsIndustrial - Distribution$1.7M
RLBDReal Brands, Inc.HealthcareDrug Manufacturers - Specialty & Generic$269,064
SKYISky Century Investment, Inc.HealthcareDrug Manufacturers - Specialty & Generic$223,725
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
CANNTrees CorporationHealthcareOTC$4.1M
CANQFCanaQuest Medical Corp.HealthcareOTC$6.6M
CATV4Cable TV International, Inc.HealthcareOTC$865,619
CBDDCBD of Denver Inc.HealthcareOTC$980,918
CBDHFHempfusion Wellness Inc.HealthcareOTC$1,635
CBDLCBD Life Sciences Inc.HealthcareOTC$375,394
CBDXCurative Biosciences, Inc.HealthcareOTC$51,578
CBDYTarget Group Inc.HealthcareOTC$863,836
CBGLCannabis Global, Inc.HealthcareOTC$28,410
CBIHCannabis Bioscience International Holdings, Inc.HealthcareOTC$5.2M
CBSTFThe Cannabist Company Holdings Inc.HealthcareNYSE$14.5M
CBWTFAuxly Cannabis Group Inc.HealthcareOTC$121.4M
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Levitee Labs Inc., and how their positions are changing. At a $369,155 market value, institutional positions materially move Levitee Labs Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Levitee Labs Inc. executives and directors. Shares of Levitee Labs Inc. have traded between $0.0000 and $0.0027 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Levitee Labs Inc.. Levitee Labs Inc. is a $369,155 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Levitee Labs Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Levitee Labs Inc.. Coverage tracks Levitee Labs Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Levitee Labs Inc.

News

Latest Market News